Sequitur develops RNAi and antisense research products.

History:

Sequitur was acquired by Invitrogen in 2003.

Employment

Email:

Fax:

Mail:

General Info:

Ticker:

Employees:

Regions:
Northeast

Research Focus:
Instrumentation/Reagents RNAi

 

Profiles:

 

News:

Keywords: 

Strategic Partnerships: Discovery Genomics